Australia unites taking small steps to make a big difference for melanoma research
23 March 2016
Melanoma March events have been an outstanding success across the country, with more than 6,000 dedicated supporters turning out for marches across 23 locations over the last month. Well over $600,000 has been raised, with two weeks of the campaign still remaining.
The Melbourne event, held early in March, attracted around 1,500 supporters, while 800 turned out for the Brisbane march last weekend. Over 700 supporters, including NSW Premier Mike Baird and rugby legend John Eales, braved the ominous clouds at Manly, while the inaugural march in Penrith attracted 500 people.
A team of volunteers and MIA staff ensured the events ran smoothly, arriving on site well before dawn to help set up, managing registrations, selling merchandise and staying back to pack up after events. MIA’s clinicians also attended events sharing their clinical insights and experiences with local crowds.
MIA’s CEO Carole Renouf who walked at the Wollongong and Manly marches said: “It takes an incredible amount of work behind the scenes to ensure events go to plan. We couldn’t do it without our incredible volunteers including staff members who took time out of their weekends to help. It was a real team effort and it was fantastic to see so many staff involved.
“I’d also like to thank our patients who bravely shared their stories with media and spoke at events. I was moved and inspired to hear about their experiences. They are the reason we do what we do.”
The final Melanoma March will be in Darwin on Sunday 10 April.
Founding father recognised for outstanding cancer care
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Melanoma researchers shine at the State's premier cancer awards ceremony
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
Enhancing melanoma treatment response through gut bacteria
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
Melanoma March is just around the corner!
2018 will be bigger than ever, and a little bit different.
Comparing melanoma risk in similar populations across different latitudes
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
What causes melanoma in 90% of young Australians?
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
Early lymph node check is saving lives in melanoma patients
Congratulations to Associate Professor Anne Cust
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
Smoking linked to increased risk of melanoma spreading
New research has shown that melanoma patients who smoke have an increased risk of their disease progressing compared to patients who do not smoke.
Research boost to improve outcomes for melanoma patients
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
Highlights in melanoma research from ESMO
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers stopping melanoma in its tracks
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
Virus-antibody combo shows promise for treating advanced melanoma
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It's time to outlaw sunburn on reality TV shows - enough is enough
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Identifying markers for optimal response
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
Global Melanoma Research Report - July
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
A day in the life of... Sarah Lane
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Differentiating moles from melanoma
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
Introducing SunSense Sunscreen
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.